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 
Abstract—The Leptin hormone is a product of the obesity 
gene, a key regulator of feeding and energy expenditure.The 
World Health Organization (WHO) predicts 11.1 million 
deaths globally and 71% deaths in developing countries due 
to Coronary Artery Disease (CAD) by 2020 A.D. CAD has 
been associated with alterations in lipid metabolism, which 
include hyper-triglyceridemia and significantly reduced 
HDL-c. The increase in the concentration of cholesterol is 
attributable to LDL cholesterol because the high density 
lipoprotein (HDL) cholesterol is typically reduced. The study 
is aimed at determining the effect of leptin hormone on 
fasting serum lipid profile, atherogenic index (AI) and 
Random Blood glucose (RBG) inWistar rats following a diet 
regime and leptin injection.Fourty (40) Wistar rats (male 
n=20, female=20), age 9weeks and weighing between 
77.2g-123.0g were randomly divided into two (2) groups of 5 
rats per sub-group. All groups were maintained ad-libitum 
on experimental diets and water for a period of 10weeks. 
Group 1 (A1 and B1); the control received standard rat feed, 
group 2 (A2 and B2) received high fat diet (margarine, 90%) 
mixed with some standard rat feed (10%), group 3 (A3 and 
B3) received protein diet (soya beans, 100%) and group 4 (A4 
and B4) received carbohydrate diet (cereal, 100%). The leptin 
hormone was given intra-peritoneal for a period of two (2) 
weeks.The resultshowed a significant difference (P<0.05) in 
the Tot-c, TG, VLDL-c, LDL-c and RBG in the pre-test and 
post-test periods, but there was no significant difference 
(P>0.05) for the calculated atherogenic index (AI). There was 
a significant difference (P<0.05) and sexual dimorphism for 
HDL-c and AI respectively and no significant difference 
(P>0.60) for Tot-c, TG, VLDL-c, LDL-c and RBG. It also 
showed a low LDL-c, low TG, low VLDL-c, low Tot-c and 
high HDL-c which resulted in a low AI in the male gender. 
The RBG was increased after the injection of the leptin 
hormone in all the groups. There was no sexual dimorphism 
in RBG. The result implies that the male gender is at a lower 
risk developing coronary artery disease (CAD). 
Index Terms— Atherogenic index, Leptin hormone, Random 
blood glucose, Wistar rats 
 
I. INTRODUCTION 
  Leptin is a 167-amino acid peptide with a four-helix bundle 
moiety (motif) similar to that of a cytokine [1], [2], it is 
produced predominantly in the adipose tissue but is also 
expressed in a variety of other tissue, including placenta, 
ovaries, mammary epithelium, bone marrow and lymphoid 
tissues [3].Leptinbinds to leptin receptors (ObRs) located 
 
 
throughout the central nervous system and peripheral tissues 
[4]. The Leptin acts on receptors in the hypothalamus where it 
inhibits appetite, counteracting the effects of neuropeptide Y 
(a potent feeding stimulant secreted by cells in the gut and in 
the hypothalamus), and also promote the synthesis of 
alpha-melanocyte stimulating hormone ( -MSH) an appetite 
suppressant. The absence of leptin (or its receptor) leads to 
uncontrolled food intake and resulting obesity [5]. Obese 
zucker rats had the highest plasma leptin concentrations, and 
Sprague-Dawley rats had the lowest (Figure 1) [6]. The 
half-life of circulating leptin (approximately 25min) is 
constant over a range of adiposity [7]. Normal values of 
plasma leptin in different strains of rats.[6] 
Changes in plasma insulin subsequent to the consumption of 
high-fat diets may alter leptin production from a dipocyctes. 
Leptin treatment enhances insulin sensitivity in normal rats, 
as indicated by increased insulin-stimulated glucose 
utilization in peripheral tissues [8].It also decreases plasma 
glucose and/or insulin concentrations of normal animals in 
the post-absorptive state. Evidence indicates that glucose 
metabolism rather than insulin itself is the main determinant 
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Figure 1: Plasma Leptin Concentrations in various  strain of rats 
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for leptin expression in adipose tissue [9]. 
 The World Health Organization (WHO) predicts 11.1 
million deaths globally and 71% deaths in developing 
countries due to Coronary Artery Disease (CAD) by 2020 
A.D [10].CAD has been associated with alterations in lipid 
metabolism, which include hyper-triglyceridemia and 
significantly reduced HDL-c [11].The increase in the 
concentration of cholesterol is attributable to LDL cholesterol 
because the high density lipoprotein (HDL) cholesterol is 
typically reduced [12].Leptin has been demonstrated to 
reduce triglycerol (TG) content in various peripheral tissues 
such as liver, muscle and pancreatic cells [13] and to partition 
free fatty acid (FFA) toward oxidation and away from storage 
in oxidative skeletal muscle [14]. High fat-diet in rodents 
result in a diminished metabolic response to peripheral leptin 
injections and impaired leptin transport across blood-brain 
barrier [14]. 
II. METHOD 
A. Animals 
Male and female Wistar rats (n = 40, male= 20, 
(72.9-126.4)g,  female= 20, (77.2-123.0)g, age= 9 weeks), 
were purchased from the university of Jos, Nigeria, animal 
house. They were then divided into 2 main groups of male 
(Group A) and female (Group B) of n = 20 each. Each group 
was divided into 4 (four) sub-groups of n = 5 per group. The 
rats were studied in the course of the experiment in two 
different periods or phases, termed „diet and treatment 
period‟. The animals were housed in groups of five per cage 
for the period of the experiment. They were humanely treated 
according to the Helsinki declaration for the care of animals 
after obtaining clearance. 
 
B. Grouping 
Group A (male, n = 20) Group B (Female, n=20) 
Group A1 (n=5)   Group B1 (n=5) 
Group A2 (n=5)   Group B2 (n=5) 
Group A3 (n=5)   Group B3 (n=5) 
Group A4 (n=5)   Group B4 (n=5) 
C. Diets  
 All rats were maintained ad libitum on the experimental 
diets and water for a period of 10 weeks. Four feeding 
regimes were used. These include: 
1. Normal rat chow (group A1 and B1) (control diet) 
(100%) (standard rat chow) 
2. Fat meal (group A2 and B2), (high-fat) margarine (90%) 
mixed with standard rat chow (10%).  
3. Protein meal (Group A3 and B3), soya beans diet (100%) 
4. Carbohydrate (group A4 and B4), cereal diet (100%) 
III. TEST PROCEDURES  
The Fasting serum lipid profile (f-SLP); total cholesterol 
(Tot-c), triglyceride (TG), very low density lipoprotein 
(VLDL-c), low density lipoprotein (LDL-c), high density 
lipoproteins (HDL-c)and RBG were measured using an 
automated spectrophotometer(SP-1104, P/N0-KJ2C1106, 
Baur Biomedical Electronics (GmbH) made in Germany, 
2003) at the National Veterinary Research Institute (NVRI) 
Laboratory, Vom, Jos, Plateau State, Nigeria. The 
Atherogenic Index (AI) was calculated using 
Friedewaldformular: 
LDL-c = Tot-c – VLDL-c 
where VLDL-c = TG/2.2 [15] 
 Leptinhormone (Leptin rat recombinant (Cat# 213-10261, 
Lot# 07112118, Raybiotech.Inc, stored at 40C for up to one 
month and freeze-thaw cycles avoided) was purchased from 
Bio-Vision Incorporated, 155 S Milpitas Blvd. Milpitas, CA 
95035, USA through Bridge Scientifik Enterprises, N0. 4 
Liberty Lane G.R.A, Flower Garden, Illorin, Kwara State, 
Nigeria). 
 
 A dose of 3.5µg of leptin was administered 
intra-peritoneally daily per rat for a period of 2 weeks 
between 12noon – 12:30pm. 
 Data were analyzed using Statistical Package for the 
Social Sciences (SPSS) version 22.0 (IBM SPSS Inc., 
Chicago, IL., USA) for Windows 8.0. The results are 
presented in mean values ± SE. Paired t-test was used to 
analyze the f-SLP and RBG. One-way ANOVA was used to 
analyze for sexual dimorphism in f-SLP and RBG for pre-test 
and post- test periods. Level of significance was at P< 0.05. 
 
IV. RESULTS 
TABLE I: Effect of leptin hormone on f-SLP and RBG for 
pre-test and post-test periods 
            Treatment        N    Mean   ¹SD     ²SEM 
T-c          Pretest          37    1.79     0.24      0.04 
                Posttest        36    3.48     1.01      0.17 
HDL-c     Pretest         37    0.51     0.16      0.03 
                Posttest        36    0.91    0.42       0.07 
TG           Pretest         37    0.60    0.14       0.02 
                Posttest        36    0.89    0.20       0.03 
VLDL-c  Pretest          37    0.87    0.27       0.05 
                Posttest        36    1.58    0.46       0.08 
LDL-c    Pretest           37    0.97    0.14       0.02 
               Posttest         36    1.90    0.54       0.09 
AI           Pretest           37    3.84   1.10        0.18 
               Posttest         36    4.47   2.07         0.35 
RBG       Pretest           37    2.62    0.39       0.64 
               Posttest         36    6.40   2.66         0.44 
There was a significant difference (P=0.01) in the Tot-c, TG, 
VLDL-c, LDL-c, HDL-c and RBG in the pre-test and 
post-test periods, but there was no significant difference 
(P=0.11) for the calculated atherogenic index (AI). The 
results suggest that having a significant difference in f-SLP 
does not translate to a high or significant AI. 
¹Standard Deviation, ²Standard Error of Mean. 
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TABLE II: Effect of leptin hormone on serum 
lipids and RBG for gender 
                                   N        Mean     ¹SD      ²SEM 
T-c            Male        36        2.57       1.13       0.19      
                 Female     37        2.67       1.11       0.18 
                 Total        73        2.62       1.12       0.13 
HDL-c      Male        36        0.81       0.48       0.08 
                 Female     37        0.60       0.18       0.03 
                 Total        73        0.70       0.37       0.04 
TG            Male        36        0.72       0.25       0.04 
                 Female     37        0.76       0.19       0.03 
                 Total         73       0.74       0.22       0.03 
VLDL-c   Male         36        1.20      0.53       0.09 
                 Female     37        1.25       0.52      0.09 
                 Total        73        1.22       0.52       0.06 
LDL-c      Male         36        1.40       0.62      0.10 
                 Female     37        1.45       0.60      0.10 
                 Total        73         1.42      0.61       0.07 
AI             Male        36         3.72      1.65       0.28 
                 Female     37        4.57       1.60       0.26 
                 Total        73        4.15       1.67       0.20 
RBG         Male        36        4.66       2.91       0.49 
                 Female     37        4.31       2.44       0.40 
                Total         73        4.48       2.67      0.31 
 
There was a significant difference (P=0.02, 0.03) in sexual 
dimorphism for HDL-c and AI respectively and no significant 
difference (P>0.60) for Tot-c, TG, VLDL-c, LDL-c and RBG. 
This may suggest a sexual dimorphism in HDL-c and AI. 
¹Standard deviation, ²Standard Error of Mean 
 
Fig.2: Comparison of the means for gender in f-SLP and 
RBG. 
There is an obvious increase in the AI of the female subjects 
when compared to that of the males. 
 
 Fig.,3: Comparison of subjects for Pre-test and Post-test 
means in serum lipids. 
 
 There is an increase in all the measured parameters during 
the post-test period especially that of T-c (Tot-c) and AI. 
V. DISCUSSION 
A. Effect of leptin on fasting serum lipid profile and 
atherogenic index (AI) 
 Lipid profile refers to some routinely done 
biochemical tests to assess the atherogenic status of 
individuals at risk of coronary artery disease (CAD). It 
includes serum triacylglycerol (TG), serum total 
cholesterol (T-c) and its sub fractions like (High density 
lipoprotein) HDL-c and (low density lipoprotein) LDL-c 
[16]. The Framingham heart study over years has 
established the role of deranged lipid profile in the 
progression of (Coronary Artery Disease) CAD and 
deranged LDL-c levels are the primary target for treatment 
[16]. 
The result on f-SLP and RBG showed a significant difference 
(P<0.05) in the Tot-c, TG, VLDL-c, LDL-c and RBG in the 
pre-test and post-test periods, but there was no significant 
difference (P>0.05) for the calculated atherogenic index (AI), 
which means even though the f-SLP result is significant, the 
Atherogenic Index of Plasma (AIP) being insignificant  
showed that the animals are not at risk of developing CAD. 
This indicates that using only the serum lipid profile is not 
enough to take a decision about the significance or 
insignificance of a test, a further calculated lipid ratio is 
needed [17]. in a study on performing regression analyses, it 
found that AIP contributes maximum among the four ratios, 
approx. 31%, Castelli‟s Risk Index I (CRI-I) 
20%,Atherogenic Coefficient (AC) with 17% and Castelli‟s 
Risk Index II  (CRI-II) with 13% to the risk of developing 
CAD [17]. Hence, for our research AIP was used. AIP is 
being used by some practitioners as a significant predictor of 
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atherosclerosis. It has been suggested that low AIP values are 
associated with low cardiovascular risk and high AIP values 
with high cardiovascular risk [18]. 
A. Effect of leptin hormone on fasting serum lipid profile on 
sexual dimorphism 
 The study showed no significant difference (P>0.05) in the 
Tot-c, TG, VLDL-c and LDL-c and a significant difference 
(P<0.05) in the HDL-c and AI when the gender difference was 
analyzed. This result has further supported our earlier results 
that the leptin hormone has a more effective action on the male 
gender. In figure 1, the graph showed a low LDL-c, low TG, 
low VLDL-c, low Tot-c and high HDL-c which result in a low 
AI in the male. Hence the male gender is at a lower risk of 
developing CAD. Our study is supported by an 
INTERHEART- South Asia study by [19], which states that 
dyslipidaemia has been identified as one of the most important 
risk factor associated with CAD, with Low HDL-c, high TG 
and high LDL-c levels associated with increased incidence of 
CAD [19]-[20]. 
B. Effect of leptin on random blood glucose (RBG) 
There was a significance difference (P<0.05) in the RBG 
between the pre-test and post-test periods. The RBG is lower 
in the pre-test period than the post-test period. It is higher in 
rats fed carbohydrate, followed by fat then protein and lower 
in rats fed standard rat chow. The result suggested that the 
administered leptin did not decrease or maintain the normal 
level of RBG; it increased it. One of leptin‟s metabolic roles 
is to enhance insulin sensitivity in normal rats by increasing 
peripheral tissue utilization of glucose [8] and hence, the 
glucose level normally decreases with the administration of 
leptin. Our research is however contrary to this but it is 
similar to that of [21], which stated that, there could be a 
different form of leptin resistance (in combination with 
insulin resistance and weight gain) that easily arises in 
laboratory animals (such as rats), as soon as they are given 
unlimited (ad libitum) access to palatable energy-dense foods 
[22] and it is reversed when these animals are put on low 
energy-density chow [23]. There was no significant 
difference (P>0.05) and sexual dimorphism in RBG. This 
may suggest that the hormone action on RBG has no 
predilection for gender. [24] calculated that 42% of leptin‟s 
hypoglycemic action was independent of weight reduction 
[24]. In contrast, the effects of leptin on whole body glucose 
metabolism in non-obese, non-diabetic animals remain 
inconsistent, but in general, short-term administration of 
leptin does not affect glucose metabolism [25]-[26]. 
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